Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events

Jessica M. Logan, Doug A. Brooks, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

Research output: Contribution to journalArticlepeer-review

26 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science